Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corteva Inc. Common Stock (CTVA) vs Twist Bioscience Corp (TWST) Price & Performance

Corteva Inc. Common StockTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Corteva Inc. Common Stock vs Twist Bioscience Corp — how do they compare? Corteva Inc. Common Stock trades at $13.75 (market cap $9.64B), while Twist Bioscience Corp trades at $157.96 (market cap $10.32B). The key difference: Corteva Inc. Common Stock and Twist Bioscience Corp are close in size by market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Twist Bioscience Corp for 27 Days on average.

CTVATWST
Market Cap
$9.64B$10.32B
Volume
41,241,2555,894,998
Sector
Basic MaterialsHealth
52-Week High
$90.51$205.00
52-Week Low
$11.92$25.45
Typical Hold Time
0 Days27 Days
Enterprise Value
$12.15B$10.24B
Dividend Yield
4.98%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corteva Inc. Common Stock

No Aura AI signal available yet.

Twist Bioscience Corp

TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.

The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTVA
100% Buy0% Sell
Avg holding period · 0 Days
TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Corteva Inc. Common Stock

Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.

Read more on CTVA →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →